29.55
-0.26 (-0.87%)
| Penutupan Terdahulu | 29.81 |
| Buka | 29.48 |
| Jumlah Dagangan | 668,796 |
| Purata Dagangan (3B) | 1,706,254 |
| Modal Pasaran | 4,781,278,720 |
| Harga / Pendapatan (P/E TTM) | 12.90 |
| Harga / Pendapatan (P/E Ke hadapan) | 20.37 |
| Harga / Jualan (P/S) | 3.26 |
| Harga / Buku (P/B) | 3.64 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 Feb 2025 - 17 Feb 2025 |
| Margin Keuntungan | 22.15% |
| Margin Operasi (TTM) | 27.70% |
| EPS Cair (TTM) | 2.29 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -0.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 93.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 28.33% |
| Nisbah Semasa (MRQ) | 3.45 |
| Aliran Tunai Operasi (OCF TTM) | 355.96 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 162.09 M |
| Pulangan Atas Aset (ROA TTM) | 8.98% |
| Pulangan Atas Ekuiti (ROE TTM) | 29.23% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Alkermes plc | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.38 |
|
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.30% |
| % Dimiliki oleh Institusi | 113.80% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 43.00 (Cantor Fitzgerald, 45.52%) | Beli |
| Median | 37.00 (25.21%) | |
| Rendah | 26.00 (JP Morgan, -12.01%) | Pegang |
| Purata | 35.57 (20.37%) | |
| Jumlah | 5 Beli, 2 Pegang | |
| Harga Purata @ Panggilan | 26.87 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Mizuho | 13 Nov 2024 | 40.00 (35.36%) | Beli | 29.24 |
| Stifel | 05 Nov 2024 | 36.00 (21.83%) | Beli | 28.37 |
| Cantor Fitzgerald | 25 Oct 2024 | 43.00 (45.52%) | Beli | 26.09 |
| 10 Oct 2024 | 48.00 (62.44%) | Beli | 27.37 | |
| Goldman Sachs | 25 Oct 2024 | 30.00 (1.52%) | Beli | 26.09 |
| HC Wainwright & Co. | 25 Oct 2024 | 37.00 (25.21%) | Pegang | 26.09 |
| 14 Oct 2024 | 37.00 (25.21%) | Pegang | 29.05 | |
| JP Morgan | 25 Oct 2024 | 26.00 (-12.01%) | Pegang | 26.09 |
| Piper Sandler | 25 Oct 2024 | 37.00 (25.21%) | Beli | 26.09 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 02 Jan 2025 | Pengumuman | Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
| 25 Nov 2024 | Pengumuman | Alkermes to Participate in Upcoming Investor Conferences |
| 11 Nov 2024 | Pengumuman | Alkermes to Participate in Two Upcoming Investor Conferences |
| 07 Nov 2024 | Pengumuman | Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences |
| 24 Oct 2024 | Pengumuman | Alkermes plc Reports Third Quarter 2024 Financial Results |
| 17 Oct 2024 | Pengumuman | Alkermes to Report Third Quarter Financial Results on October 24, 2024 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |